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g.2014.0Abstract Background: Several mechanisms have been suggested for obesity in Down syndrome.
Aim of the study: Assessment of serum levels of leptin, insulin like growth factor-I (IGF-I), thy-
roid stimulating hormone (TSH) and free thyroxin (FT4) in a prepubertal Egyptian sample of chil-
dren with DS compared to their age and sex matched healthy controls and sibs of some of them.
Subjects and methods: A prospective case control study was conducted on 80 children, classiﬁed
as follows: Groups I & II: enrolled 20 cases with DS for each, sibs were studied only for group I,
Group III: 20 healthy siblings of group I, and Group IV: 20 healthy controls. Anthropometric mea-
surements, serum leptin, IGF-1, TSH, and FT4 assessment using enzyme linked immuno-sorbent
assay (ELISA) were carried out for all studied children.
Results: DS children whether with studied sibs or without studied sibs had signiﬁcantly higher
mean values of leptin levels compared to sibs of group I & IV (P= 0.0001 for all). Meanwhile,
mean values of IGF-I showed statistically insigniﬁcant differences between all studied groups
(p> 0.05 for all). Studied DS children whether with studied sibs or without studied sibs had signif-
icantly higher mean values of TSH levels compared to sibs of group I and controls (P= 0.0001 for
all). Mean values of FT4 were signiﬁcantly higher in enrolled DS without their studied sibs com-
pared to sibs of group I (p= 0.01), while mean values of FT4 were signiﬁcantly lower in sibs of
group I compared to controls (p= 0.001).2978734.
(E.A. Zaky).
Shams University.
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Figure 1 Statistically signiﬁcant p
between serum leptin (ng/l) levels and
DS cases (group I & II). (r= 0.53, P
132 H.H. El Gebali et al.Conclusion: Serum leptin levels were signiﬁcantly higher in studied DS children compared to
both studied sibs and healthy controls and they were also positively correlated with BMI in studied
DS children and their sibs highlighting a possible role of body fat% and leptin values in the path-
ogenesis of obesity in DS children.
 2014 Production and hosting by Elsevier B.V. on behalf of Ain Shams University.1. Introduction
Down syndrome (DS) is the most common chromosomal
anomaly among live-born infants, occurring at a frequency
of one in 700 live births [1]. Individuals with DS are at in-
creased risk for several endocrinological conditions, includ-
ing hypothyroidism, growth retardation, diabetes mellitus,
and obesity [2,3]. The reason for the increased risk of obes-
ity in DS individuals is unclear, but several mechanisms
have been suggested, including a decreased resting metabolic
rate [4,5], and differences in physical activity patterns [6].
With the increase in the life expectancy of people with
DS, obesity and related morbidity and mortality are emerg-
ing as important long term consequences [3]. Adipokines
such as leptin have been implicated in the pathophysiology
of obesity. Leptin is a hormone secreted by adipocytes, act-
ing in the hypothalamus to suppress appetite and regulate
body weight [7]. It is positively correlated with percentage
of body fat; thus, it is postulated that obese individuals
have some degree of leptin resistance [8]. It is unclear
whether this mechanism is also at work in children with
DS.
The current study was carried out in accordance to the code
of Ethics of the World Medical Association (Declaration of
Helsinki) for experiments involving humans. This study was
also done after taking consent of legal caregivers of enrolled
patients and controls as well as the acceptance of the Ethics
Committee of our University. It aimed at the assessment of
serum levels of leptin, IGF-I (insulin like growth factor-I),
and thyroid proﬁle (TSH&FT4) in a sample of prepubertal
Egyptian children with Down syndrome compared to their
age and sex matched healthy controls and the sibs of some
of them in order to investigate the hormonal mechanisms of
obesity in DS children.001**)
30 40 50
ositive correlation recorded
BMI (kg/m2) of all studied
= 0.0001**).2. Subjects and methods
The present study was designed to be a prospective case con-
trol study that was conducted on 80 children. They were clas-
siﬁed into four groups: Group I: included 20 cases with DS
whose siblings were studied as well; 9 males (45%) and 11 fe-
males (55%). Their ages ranged from 3 to 10 years with a mean
value of 6.4 ± 2.3 years. Group II: included 20 cases with DS
without studied siblings; 10 males (50%) and 10 females
(50%). Their ages ranged from 3 to 11 years with a mean value
of 7.1 ± 2.6 years. Children of both groups were recruited
from the Special Needs Clinic, Ahmed Maher Teaching Hospi-
tal and Special Needs Unit, Institute of Postgraduate of Child-
hood Studies, Ain Shams University during the period of
clinical part of the study from January 2011 to May 2011.
Group III: included 20 healthy siblings of group I; 6 males
(30%) and 14 females (70%). Their ages ranged from 5 to
11 years with a mean value of 9.06 ± 1.7 years. Group IV: in-
cluded 20 healthy control children; 10 males (50%) and 10
females (50%). Their ages ranged from 3.75 to 10.5 years with
a mean value of 6.6 ± 1.9 years. They were sibs of outpatients
attending the Pediatrics Clinic, Ahmed Maher Teaching Hos-
pital during the clinical period of study from January 2011
to May 2011.
Inclusion criterion for all studied children was a BMI be-
tween 5th to 95th percentile for age and sex. Exclusion criteria
for DS cases (group I & II): Down syndrome associated with
(1) cancer including leukemia, (2) congenital heart disease
necessitating open heart surgery, (3) children with history of
intestinal resection or (4) other chronic conditions affecting
the growth or energy balance.
All children enrolled in the current study were subjected to
the following: (I) full history taking: laying stress on age, sex,
consanguinity, dietetic history, history of perinatal hazards,(r = 0.709, p=0.0001**)
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Figure 2 Statistically signiﬁcant positive correlation recorded
between serum leptin (ng/l) levels and body fat% of all DS cases
(group I & II). (r= 0.709, p= 0.0001**).
Leptin, insulin like growth factor-1, and thyroid proﬁle in DS 133past history of any important illness or event and family his-
tory of similar conditions, (II) thorough clinical examination
with special emphasis on: general and all body systems’ exam-
ination: including chest, heart, abdomen and neurological
evaluation, (III) auxological assessment including measure-
ments of weight (in kilograms), height (in meter), BMI and
skin fold thickness. Weight was recorded while subjects of
the study were wearing light clothes as possible with no shoes
[9]. Height: each subject was measured with his head in the
frankfort plane (look straight ahead), heals, knees, buttocks
and head touching the vertical plane with the feet close to-
gether without shoes. Hats and head ornaments were removed.
Three recordings were done and the average was calculated [9].
BMI was calculated as weight in kilogram divided by height in
meter squared [10]. Skin fold thickness is useful in determining
not only the amount of subcutaneous fat but also of total body
fat [11]. There were certain sites in the body that were chosen
for measurement but the technique was the same for all. Skin
fold thickness was measured by using skinfold calipers. The
skinfold was ﬁrmly grasped and slightly lifted up between
the index ﬁnger and thumb of the left hand, care being taken
not to include the underlying muscles. The skinfold caliper
was applied about 1 cm below operator’s ﬁngers at a depth
equal to the skinfold. The dial was read approximately 4 s after
the pressure from operator’s hands released on the lever arm of
the caliper [12]. The caliper exerted a constant pressure (10 gm/
mm2) through the whole range of skinfold thickness at all
distances of separation of jaws. Three readings were taken
for the same area and the average was calculated [13].Triceps,
biceps, subscapular, and supra iliac skinfolds were measured.
In this study the used caliper was slim guide caliper. (IV) Blood
samples were withdrawn after 12 h overnight fast from all
children, centrifuged and sera were separated and stored in
20 C for subsequent use. Measurement of serum levels of
leptin, IGF-I, TSH and FT4 using kits for ELISA (Enzyme
Linked Immuno-sorbent Assay) was carried out for all studied
children.
All statistical analyses were performed using the Statistical
package for social science (SPSS) program version 16 (2007)
[14]. Chi-Square test X2 was used to compare categorical or
qualitative variables between different studied groups. Stu-
dent’s t-test was used to compare quantitative parametric vari-Table 1 Statistical comparison between mean values of BMI (kg/m
Variable Group
Group I
DS with studied sibs
No = 20
Group II
DS-without studied sibs
No = 20
Range M± SD Range M± SD
BMI (kg/m2) 16.9–21.1 18.3 ± 0.9 17–23.2 19.4 ± 1.7
Group I VS II Group I VS III Group I VS IV
t P t P t P
2.387 0.02* 5.19 0.0001** 7.759 .0001**
N.B. Student ‘‘t’’ test was used for statistical comparison.
P value > 0.05 = statistically non signiﬁcant. P value < 0.05* = statistic
P value < 0.01** = statistically highly signiﬁcant. M: mean; SD: standar
BMI: body mass index.ables between different studied groups. The correlation
coefﬁcient (r) was calculated and used to correlate different
studied parametric variables. Probability (p) value: p values
were considered statistically insigniﬁcant when p val-
ues > 0.05, signiﬁcant at p values < 0.05, and highly signiﬁ-
cant at P values < 0.01.3. Results
There were statistically non signiﬁcant differences between DS
cases with studied sibs, DS cases without studied sibs and
healthy controls as regards age distribution (P> 0.05). On
the other hand, mean values of age were signiﬁcantly lower in
DS cases with studied sibs, DS cases without studied sib, and
healthy controls compared to sibs of group I (P= 0.0001,
0.01, and 0.0001, respectively). The statistical analysis of the ob-
tained data showed also non signiﬁcant differences between
studied groups as regards sex distribution (p> 0.05). Consan-
guinity rate was 15% in DS cases with studied sibs compared
to 20% inDS cases without studied sibs and 10% in healthy con-
trols (p> 0.05 for all). Family history of obesity was encoun-
tered in 7 DS cases with studied sibs (35%) compared to 4
cases (20%) of DS cases without studied sibs and 6 cases
(30%) of healthy controls (p> 0.05 for all).
Mean values of BMI were signiﬁcantly higher in DS cases
with studied sibs compared to their sibs and healthy controls;
P= 0.0001, 0.0001 respectively. Also, mean values of BMI
were signiﬁcantly higher in DS cases without studied sibs com-
pared to DS cases with studied sibs, sibs of group I and healthy
controls; P= 0.02, 0.0001,0.0001 respectively. Also, mean val-
ues of BMI were signiﬁcantly higher in sibs of group I com-
pared to healthy controls; P= 0.003; Table 1
There were statistically non signiﬁcant differences between
DS cases with studied sibs and DS cases without studied sibs
as regards body fat% (P= 0.4). On the other hand, mean val-
ues of body fat% in DS cases with studied sibs were signiﬁ-
cantly higher compared to their sibs and healthy controls
(P= 0.0001,0.0001). Also, mean values of body fat% were
signiﬁcantly higher in DS cases without studied sibs compared
to sibs of group I and healthy controls (p= 0.0001, 0.001
respectively). Also, mean values of body fat% were signiﬁ-2) of different studied groups.
Group III
Sibs of group I
No = 20
Group IV
Healthy controls
No = 20
Range M± SD Range M± SD
15.6–18.1 16.8 ± 0.8 14.8–18.1 15.9 ± 0.9
Group II VS III Group II VS IV Group III VS IV
t P t P t P
5.937 0.0001** 7.77 0.0001** 3.171 0.003*
ally signiﬁcant.
d deviation.
Table 2 Statistical comparison between mean values of body fat% of different studied groups.
Variable Group
Group I
DS with studied
sibs No = 20
Group II
DS-without studied
sibs No = 20
Group III
Sibs of group I No = 20
Group IV
Healthy controls No = 20
Range M± SD Range M± SD Range M± SD Range M± SD
Body fat% 17.6–29.8 24.5 ± 3.6 17.3–29.5 23.5 ± 3.5 15.4–22.8 20.2 ± 2.5 13.3–23 17.5 ± 3.0
Group I VS II Group I VS III Group I VS IV Group II VS III Group II VS IV Group III VS IV
t P t P t P t P t P t P
0.81 0.4 4.314 0.0001** 6.54 0.0001** 3.451 0.001** 5.769 .0001** 2.96 0.005**
N.B. Student ‘‘t’’ test was used for statistical comparison.
P value > 0.05 = statistically non signiﬁcant. P value < 0.05 = statistically signiﬁcant.
P value < 0.01** = statistically highly signiﬁcant.
Table 3 Statistical comparison between mean values of serum leptin level of different studied groups.
Variable Group
Group I
DS with studied sibs
No = 20
Group II
DS-without studied sibs
No = 20
Group III
Sibs of group I
No = 20
Group IV
Healthy controls
No = 20
Range M± SD Range M± SD Range M± SD Range M± SD
Leptin (ng/ml) 10–39 21.2 ± 7.2 10–39 20.3 ± 8.1 2.4–8 5.2 ± 1.6 2.5–10 5.2 ± 2.05
Group I V II Group I VS III Group I VS IV Group II VS III Group II VS IV Group III VS IV
t P t P t P t P t P t P
0.354 0.7 9.64 0.0001** 9.5 0.0001** 8.103 0.0001** 8.011 0.0001** 0.025 0.9
N.B. Student ‘‘t’’ test was used for statistical comparison.
P value > 0.05 = statistically non signiﬁcant. P value < 0.01** = statistically highly signiﬁcant.
M: mean; SD: standard deviation.
134 H.H. El Gebali et al.cantly higher in sibs of group I compared to healthy controls
(p= 0.005); Table 2
Mean values of serum leptin levels in DS cases with stud-
ied sibs were signiﬁcantly higher compared to their sibs and
healthy controls (p= 0.0001,0.0001 respectively). Also, ser-
um leptin levels were signiﬁcantly higher in DS cases with-
out studied sibs compared to sibs of group I and healthyTable 4 Statistical comparison between mean values of IGF-I leve
Variable Group
Group I
DS with
studied sibs
No = 20
Group II
DS-without
studied sibs
No = 20
Range M± SD Range M± SD
IGF-I (ng/l) 77.5–170 125.1 ± 29 57.5–220 127.4 ±
Group
I VS II
Group
I VS III
Group
I VS IV
t P t P t P
0.22 0.82 0.145 0.88 0.170 0.86
N.B. Student ‘‘t’’ test was used for statistical comparison.
P value > 0.05 = statistically insigniﬁcant. M: mean; SD: standard devia
IGF-I: insulin like growth factor-I.controls (P= 0.0001,0.0001). On the other hand, there were
statistically non signiﬁcant differences between DS cases
with studied sibs and DS cases without studied sibs as re-
gards serum leptin levels (P= 0.7). Also, there were statisti-
cally non signiﬁcant differences between sibs of group I and
healthy controls as regards serum leptin levels (P= 0.9);
Table 3l (ng/l) of different studied groups.
Group III
Sibs of
group I
No = 20
Group IV
Healthy
controls
No = 20
Range M± SD Range M± SD
35.7 75.5–155 123.9 ± 22.8 47.5–172 126.7 ± 29.5
Group
II VS III
Group
II VS IV
Group
III VS IV
t P t P t P
0.366 0.7 0.067 0.9 0.332 0.7
tion.
Table 5 Statistical comparison between mean values of serum TSH levels of different studied groups.
Variable Group
Group I
DS with studied sibs
No = 20
Group II
DS-without studied sibs
No = 20
Group III
Sibs of group I
No = 20
Group IV
Healthy controls
No = 20
Range M± SD Range M± SD Range M± SD Range M± SD
TSH (uIU/ml) 2.9–5 4.2 ± 0.7 2.1–5 4.1 ± 0.85 1.3–3.6 2.3 ± 0.77 1.3–3.9 2.8 ± 0.76
Group I VS II Group I VS III Group I VS IV Group II VS III Group II VS IV Group III VS IV
t P t P t P t P t P t P
0.34 0.7 8.23 0.0001** 6.26 0.0001** 7.164 0.0001** 5.36 0.0001** 1.92 0.06
N.B. Student ‘‘t’’ test was used for statistical comparison.
P value > 0.05 = statistically non signiﬁcant. P value < 0.01** = statistically highly signiﬁcant.
M: mean; SD: standard deviation.
TSH: thyroid stimulating hormone.
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in females compared to males of different studied groups
(P< 0.01).
There were statistically non signiﬁcant differences between
different studied groups regarding their serum IGF-I concen-
trations (p> 0.05 for all); Table 4
Mean values of serum TSH levels were signiﬁcantly higher
in DS cases with studied sibs compared to their sibs and
healthy controls (p= 0.0001, 0.0001, respectively). Also, mean
values of serum TSH levels were signiﬁcantly higher in DS
cases without studied sibs compared to sibs of group I and
healthy controls (P= 0.0001,0.0001). On the other hand,
there were statistically non signiﬁcant differences between DS
cases with studied sibs and DS cases without studied sibs as re-
gards serum TSH levels (P= 0.7). Also, there were statistically
non signiﬁcant differences between sibs of group I and healthy
controls as regards serum TSH levels (P= 0.06); Table 5
Mean values of serum free thyroxin levels showed statisti-
cally non signiﬁcant differences in DS cases with studied sibs
compared to DS cases without studied sibs, their sibs and
healthy controls (P= 0.2, 0.132, and 0.134 respectively). Also,
there were statistically non signiﬁcant differences between DS
cases without studied sibs and healthy controls as regards ser-
um FT4 levels (P= 0.9). On the other hand, mean values ofTable 6 Statistical comparison between mean values of serum FT4
Variable Group
Group I
DS with studied sibs
No = 20
Group II
DS-without studied sibs
No = 20
Range M± SD Range M± SD
FT4 (pmol/l) 10.5–17.7 13.3 ± 1.9 9.8–19.3 14.29 ± 2.5
Group I VS II Group I VS III Group I VS IV
t P t P t P
1.29 0.2 1.537 0.132 1.53 0.134
N.B. Student ‘‘t’’ test was used for statistical comparison.
P value > 0.05 = statistically non signiﬁcant. P value < 0.05* = statistic
P value < 0.01** = statistically highly signiﬁcant. M: mean; SD: standar
FT4: free thyroxin.serum FT4 levels were signiﬁcantly higher in DS cases without
studied sibs compared to sibs of group I; P= 0.01. Also, mean
values of serum FT4 were signiﬁcantly higher in healthy con-
trols compared to sibs of group I (p= 0.001); Table 6. Statis-
tically signiﬁcant positive correlations were recorded between
serum leptin and both BMI and body fat % in studied DS
cases with and without studied sibs; Figs. 1 and 2
4. Discussion
Obesity, a state of excess body fat, is commonly assessed using
the body mass index (BMI); a ratio of weight (kg) to height
(m2) [15]. In the current study, BMI (kg/m2) was found to be
signiﬁcantly higher in DS children with studied sibs compared
to their siblings. These ﬁndings were in agreement with Magge
et al. [16] who found that prepubertal children with DS aged 4–
10 years had higher BMI compared to their siblings, although
most subjects were not obese. Also, Samarkandy et al. [17] ob-
served that prepubertal children with DS aged 5–12 years had
higher BMI compared to their siblings. They were shorter than
their siblings, but had comparable weights. In contrast, Sharav
and Bowman [18] found that there were no signiﬁcant differ-
ences between the DS children aged 2–11 years and their sib-
lings aged 2–14 years in terms of body mass index and(pmol/l) level of different studied groups.
Group III
Sibs of group I
No = 20
Group IV
Healthy controls
No = 20
Range M± SD Range M± SD
10.5–16.2 12.5 ± 1.5 12.1–17.6 14.21 ± 1.5
Group II VS III Group II VS IV Group III VS IV
t P t P t P
2.688 0.01* 0.122 0.9 3.514 0.001**
ally signiﬁcant.
d deviation.
136 H.H. El Gebali et al.weekly caloric intake. They postulated that weight gain in chil-
dren with DS was inﬂuenced by both genetic and environmen-
tal factors, such as dietary control and involvement in physical
activity. Also, BMI (kg/m2) was found to be signiﬁcantly high-
er in DS children with studied sibs compared to healthy
controls (P= 0.0001). Similarly, BMI was found to be signif-
icantly higher in DS children without studied sibs compared to
sibs of group I and healthy controls (P= 0.0001, 0.0001,
respectively). These ﬁndings were in agreement with a study
on Saudi DS children younger than 5 years conducted by Al
Husain [19]who found that there was a trend of a steady in-
crease in the mean BMI curve for children with DS at each
age group compared with a downward trend of the mean
BMI curve for control children. The mean BMIs for both chil-
dren with DS and controls were below the international cut-off
points for BMI for overweight and obesity, at all age.
EnrolledDS childrenwith studied sibs had signiﬁcantly high-
er body fat% than their sibs. In agreement withMagge et al. [16]
who observed that prepubertal children with DS aged 4–
10 years had higher body fat percentage compared to their sib-
lings. Body fat% were found to be signiﬁcantly higher in DS
children with studied sibs compared to healthy controls
(P= 0.0001). Also, body fat% were found to be signiﬁcantly
higher in DS children without studied sibs compared to sibs of
group I and healthy controls (P= 0.001,0.0001, respectively).
Similarly, Soler Marı´n and Xandri Graupera [20] reported that
young adults with Down syndrome have higher body fat per-
centage than age and sex matched persons without DS.
Adipocytes secrete leptin hormone which rises in direct pro-
portion to adipose mass [21]. Interestingly, in obese individuals,
a persistent eating behavior (overeating) remains, although
blood leptin levels are elevated [22]. Serum leptin concentrations
correlated with percentage of body fat, suggesting that most ob-
ese persons are insensitive to endogenous leptin production. So,
it is postulated that obese individuals, with hyperleptinemia,
have some degree of leptin resistance [8]. In the present study,
serum leptin levels were signiﬁcantly higher in DS children with
studied sibs compared to their siblings. This ﬁnding could be ex-
plained by the observation that enrolled DS children had higher
percentage of body fat compared to their siblings. These ﬁndings
were in agreement with Magge et al. [16] who found that leptin
levels were higher in prepubertal children with DS compared to
their siblings. Also, they found that leptin and percent body fat
were positively associated in both groups, but with a signiﬁ-
cantly greater association among the children with DS. They
concluded that the difference in themagnitude of the association
between leptin and adiposity in DS children compared to con-
trols may represent increased leptin resistance in DS children.
Serum leptin levels were signiﬁcantly higher in DS children
with studied sibs compared to healthy controls. Similarly, ser-
um leptin levels were signiﬁcantly higher in DS children with-
out studied sibs compared to sibs of group I and healthy
controls. Also, this ﬁnding could be explained by the observa-
tion that enrolled DS children without studied sibs had higher
percentage of body fat compared to sibs of group I and healthy
controls. These ﬁndings disagree with Radunovic et al. [23]
who demonstrated that fetuses with DS had signiﬁcantly lower
plasma leptin levels than control euploid fetuses matched for
gestational age, leading to the hypothesis that damage begin-
ning from this stage may compromise the synthesis and secre-
tion of leptin. Also, Proto et al. [24] have found that total and
free leptin levels in obese women with DS were in the range ofnormal weight controls and signiﬁcantly lower than those
found in obese controls, but no signiﬁcant differences were
found in soluble receptors levels and this gave evidence against
a deﬁcit in receptor synthesis in DS. They also suggested that
low leptin levels in obese DS individuals could depend on an
impaired secretory activity of adipocytes, as leptin is released
by fat mass, and DS patients could have a lower percentage
of fat compared to controls subjects. Yahia et al. [25] found
that there were non signiﬁcant differences in serum leptin levels
among non obese prepubertal DS children aged from
2–10 years and healthy control children.
A signiﬁcant gender inﬂuence on serum leptin levels in prepu-
bertal DS children with studied sibs, DS children without stud-
ied sibs, sibs of group I and healthy children was found. Girls
had higher leptin levels compared to boys. In agreement with
several studies in normal prepubertal children conducted by
Werner et al. [26] showed a signiﬁcant gender difference espe-
cially in late puberty and adolescence. Also, Fors et al. [27]
found that gender differences in leptin levels in prepubertal chil-
dren, girls had higher leptin levels than boys, may at least in part
be explained by differences in body composition. Similarly,
Dencker et al. [28] found that in case of true gender difference
in leptin levels in young children, girls had higher mean values
than boys for leptin. They explained this difference in leptin con-
centration by a larger amount of body fat content in girls than in
boys. In contrast to these ﬁndings,Garcia-Mayor et al. [29] dem-
onstrated that before puberty, leptin levels in normal boys in-
creased in parallel with body weight, in a similar pattern to
girls. Also, Magni et al. [30] found that leptin values did not dif-
fer according to gender in prepubertal children with DS.
In the present study, serum leptin concentrations showed a
signiﬁcant positive correlation with BMI in all DS children.
Findings concerning the correlation between leptin and BMI
in DS persons were similar in many studies e.g. Cento et al.
[31] reported that leptin concentrations correlate with BMI
in adult obese women with DS. Similarly Magni et al. [30] ob-
served positive correlation between leptin concentrations and
BMI in prepubertal DS children. Also, serum leptin concentra-
tions showed a signiﬁcant positive correlation with BMI in sibs
of group I and healthy children. In agreement with Werner
et al. [26], Fors et al. [27] and Plonka et al. [32] reported that
there was a signiﬁcant positive correlation between leptin con-
centrations and BMI in healthy children. Similarly, Ostadrah-
imi et al. [33] found that serum leptin concentration correlated
positively with BMI in healthy normal, over weight and obese
Iranian reproductive age women.
There was a signiﬁcant positive correlation between leptin
levels and percent body fat in all DS children (group I & II),
the greater the percent of body fat the higher the leptin levels.
In agreement with a study conducted in prepubertal DS chil-
dren by Magge et al. [16]. Also, there were signiﬁcant positive
correlations between leptin levels and percent body fat in sibs
of group I and healthy controls. In agreement with foregoing
ﬁndings, studies conducted in healthy children by Werner
et al. [26], Fors et al. [27] and Bandini et al. [34].
In the present study, there were no signiﬁcant differences
between DS children and their siblings regarding their serum
IGF-I concentrations. These ﬁndings were in accordance with
the results of Magge et al. [16] who did not observe any signif-
icant differences between serum levels of IGF-I in healthy DS
children and their siblings. Similarly, there were no signiﬁcant
differences between DS children with studied sibs and healthy
Leptin, insulin like growth factor-1, and thyroid proﬁle in DS 137controls regarding their serum IGF-I concentrations. Also,
insulin like growth factor-I levels in DS children without stud-
ied sibs was not signiﬁcantly different from sibs of group I and
healthy controls, IGF-I levels were within normal range. These
results were in agreement with Hestnes et al. [35] who com-
pared 29 adults with chromosomally veriﬁed DS aged 21–
72 years with 29 mentally retarded controls from the same
institutions. They concluded that IGF-I level in adults with
DS was found to be in the normal general population range
and there was no signiﬁcant difference observed in IGF-I be-
tween adult with DS and other mentally retarded adult. Also,
Ragusa et al. [36] investigated IGF-I levels in prepubertal,
pubertal children with DS, normal children and adolescents
and demonstrated that IGF-I levels in DS patients were gener-
ally within the normal range. In contrast to these results, Sara
et al. [37] and Anneren et al. [38] reported low levels of IGF-I
in patient with DS during childhood and adolescence. Simi-
larly, Anneren et al. [39] reported that there were low concen-
trations of serum IGF-I in DS children aged 6 to 9 months and
its levels became normal during growth hormone treatment.
TSH levels in DS children with studied sibs were not signif-
icantly different from DS children without studied sibs and
TSH concentrations were within the normal levels. Serum
TSH levels were signiﬁcantly higher in DS children with stud-
ied sibs compared to their sibs, although TSH concentrations
were within the normal levels. In agreement with Magge
et al. [16] who found that although children requiring treat-
ment for hypothyroidism were excluded from the study, TSH
values were higher among children with DS than among their
siblings, although TSH values were within the normal range.
Serum TSH levels were signiﬁcantly higher in DS children with
studied sibs compared to healthy control children. Also, TSH
concentrations were within the normal limits. Serum TSH lev-
els were signiﬁcantly higher in DS children without studied sibs
compared to sibs of group I and healthy controls, TSH con-
centrations were within the normal levels. These results were
in agreement with Meyerovitch et al. [40] who observed higher
TSH levels in DS patients who were not diagnosed with thy-
roid disease or did not receive thyroid modulating medication
than the control group of healthy age and sex matched sub-
jects. They suggested that the upward shift in the distribution
of TSH was inherent to DS and not an indication of subclinical
hypothyroidism in a large subset of patients with DS. Simi-
larly, Yahia et al. [25] showed a signiﬁcantly higher TSH levels
in DS children than healthy children, but still within reference
range median values. In contrast to these ﬁndings, many stud-
ies showed abnormal TSH levels in DS, Magni et al. [30] found
that about 33% of studied prepubertal children with DS, who
were clinically euthyroid, had elevated TSH concentration
above the higher limits. Also, Hasanhodzic et al. [41] reported
higher frequency of thyroid dysfunction in DS patients as they
found signiﬁcantly higher values of TSH in 60% of the exam-
ined DS patients compared to the control group. Also, Chen
et al. [42] reported that there was a signiﬁcantly higher preva-
lence (18%) of thyroid dysfunction in DS patients, regarding
the elevation of TSH levels as major thyroid dysfunction.
There were no signiﬁcant differences between DS children
with studied sibs and DS children without studied sibs regard-
ing their serum FT4 levels, free thyroxin concentrations were
within the normal levels. In agreement with Magni et al. [30]
who found normal free thyroxin concentrations in prepubertal
children with Down syndrome. Serum FT4 concentrationswere not signiﬁcantly different in DS children with studied sibs
compared to their sibs, FT4 levels were within the normal lim-
its. Similarly, serum FT4 concentrations were not signiﬁcantly
different in DS children with studied sibs compared to healthy
control children, FT4 levels were within the normal limits. Ser-
um free thyroxin levels were not signiﬁcantly different in DS
children without studied sibs compared to healthy control chil-
dren, FT4 levels were within the normal limits. These results
were in agreement with Chen et al. [42] who found that serum
FT4 levels were within normal limits or close to the lower limit
of normal range in DS patients aged 12.9 to 52.5 year. Also, in
a retrospective study in DS children their mean age 4.5 years
and followed up for 6.8 years, Faria et al. [43] observed that
values of free T4 remained normal in DS children. In contrast,
Pueschel et al. [44] found that FT4 levels were signiﬁcantly
lower in Down syndrome children compared to control chil-
dren, about 16% showed the evidence of hypothyroidism.
FT4 levels were signiﬁcantly higher in DS children without
studied sibs compared to sibs of group I, although FT4 levels
were within the normal limits. Similarly, Yahia et al. [25] ob-
served that serum thyroxin levels were signiﬁcantly higher in
Egyptian DS children aged 2–10 years compared to healthy
children but still within the normal reference range. Serum free
thyroxine concentrations were signiﬁcantly higher in healthy
control children compared to healthy sibs of group I although,
FT4 levels were within the normal limits.5. Conclusion
Serum leptin levels were signiﬁcantly higher in studied DS chil-
dren with or without their sibs compared to both studied sibs
and healthy controls. Serum leptin values were found to be
positively correlated with BMI in studied DS children as well
as their sibs highlighting a possible role of body fat% and lep-
tin values in the pathogenesis of obesity in DS children.Conﬂict of interest
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